• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    GCC Closed System Drug Transfer Device Market

    ID: MRFR/Pharma/47917-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    GCC Closed System Drug Transfer Device Market Research Report By Type (Membrane-to-membrane, Needleless System), By Component (Vial Access Devices, Syringe Safety Devices, Accessories, Bag/Line Access Devices), By Closing Mechanism (Push to Turn System, Color-to-color Alignment System, Leur Lock Systems, Click to Lock Systems), By Technology (Compartmentalize Devices, Diaphragm-Based Devices, Air Filtration Devices), and By End-users (Hospitals & Clinics, Specialty Centers, Others)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    GCC Closed System Drug Transfer Device Market Research Report - Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    GCC Closed System Drug Transfer Device Market Summary

    The GCC Closed System Drug Transfer Device market is projected to grow significantly from 750 USD Million in 2024 to 1500 USD Million by 2035.

    Key Market Trends & Highlights

    GCC Closed System Drug Transfer Device Key Trends and Highlights

    • The market is expected to expand at a compound annual growth rate of 6.5 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 1500 USD Million, indicating robust growth potential.
    • In 2024, the market is valued at 750 USD Million, reflecting a strong foundation for future expansion.
    • Growing adoption of closed system drug transfer devices due to increasing safety concerns in healthcare settings is a major market driver.

    Market Size & Forecast

    2024 Market Size 750 (USD Million)
    2035 Market Size 1500 (USD Million)
    CAGR (2025 - 2035) 6.5%

    Major Players

    Saudi Aramco (SA), Qatar National Bank (QA), Emirates NBD (AE), Etisalat (AE), National Commercial Bank (SA), Oman Telecommunications Company (OM), Kuwait Finance House (KW), Bahrain Telecommunications Company (BH), Al Rajhi Bank (SA)

    GCC Closed System Drug Transfer Device Market Trends

    The growing need for efficiency and safety in drug handling in healthcare facilities is driving notable developments in the GCC closed system drug transfer device market. Stricter rules governing the usage of drug handling systems have resulted from the region's governments' emphasis on raising healthcare standards.

    The use of closed-system drug transfer devices is increasing as medical professionals grow more conscious of the dangers of drug exposure. This driver demonstrates the area's dedication to improving patient safety and shielding medical personnel from dangerous medications.

    The GCC market is expanding in terms of prospects, especially as a result of investments in healthcare technology and infrastructure. The GCC nations are improving or growing their healthcare infrastructure, which is fostering an atmosphere that will allow for the introduction and broader use of cutting-edge medical technology.

    The market for closed system drug transfer devices might be supported by public sector initiatives to upgrade healthcare offerings, particularly in nations like Saudi Arabia and the United Arab Emirates. Additionally, partnerships between foreign businesses and regional producers may result in creative solutions that meet market demands.

    Technology is increasingly being incorporated into medical equipment to make them more user-friendly and efficient, according to recent trends. In order to encourage healthcare professionals to use these devices more easily, there is a noticeable emphasis on developing systems that are both user-friendly and consistent with international safety standards.

    In order to realize the benefits, instructional initiatives that teach employees how to use these systems correctly are also growing in popularity. This trend alignment shows that the GCC region is gradually moving toward safer and more effective drug transfer procedures.

    GCC Closed System Drug Transfer Device Market Drivers

    Market Segment Insights

    Closed System Drug Transfer Device Market Type Insights

    The GCC Closed System Drug Transfer Device Market is characterized by its diverse Type segment, which includes systems such as Membrane-to-membrane and Needleless Systems.

    Membrane-to-membrane technology ensures a high level of safety by providing a barrier against contamination, making it a significant choice among healthcare professionals focused on maintaining dosage accuracy and patient safety.

    The adoption of Membrane-to-Membrane systems has gained traction due to the increasing incidence of hazardous medication exposure among healthcare personnel, thus ensuring compliance with strict regulatory frameworks and enhancing workplace safety.

    On the other hand, Needleless Systems are pivotal in reducing the risks associated with needle-stick injuries while also improving patient comfort. The significance of Needleless Systems lies in their ability to streamline the drug transfer process, minimizing the potential for cross-contamination and fostering better infection control practices.

    The growing demand for such advanced delivery systems in chemotherapy, where the risk of exposure to toxic drugs is notably high, further solidifies the position of these types in the GCC market.

    Closed System Drug Transfer Device Market Component Insights

    The Component segment of the GCC Closed System Drug Transfer Device Market plays a crucial role in enhancing the safety and efficacy of drug administration.

    Key elements such as Vial Access Devices and Syringe Safety Devices are integral in preventing contamination and ensuring that hazardous drugs are handled securely, which is increasingly vital given the rising awareness of workplace safety standards in healthcare settings across the region.

    Accessories within this segment further augment these devices, improving their usability and adaptability to various clinical environments. Bag/Line Access Devices are significant in facilitating seamless connections in drug delivery systems, thereby minimizing the risk of exposure for healthcare professionals.

    The increasing investments in healthcare infrastructure and regulatory support from GCC governments are driving the growth of the Component segment, as hospitals and clinics recognize the importance of adopting advanced drug transfer technologies to improve patient safety and streamline processes.

    Overall, as the market grows, innovation within these components will likely lead to enhanced safety protocols and more efficient healthcare delivery across the region.

    Closed System Drug Transfer Device Market Closing Mechanism Insights

    The Closing Mechanism segment of the GCC Closed System Drug Transfer Device Market plays a crucial role in ensuring the safe and efficient transfer of medications. This segment is primarily characterized by various systems, such as Push to Turn, Color-to-color Alignment, Leur Lock, and Click to Lock Systems.

    Each of these systems offers distinct advantages that cater to the specific needs of healthcare settings in the GCC region, which has been seeing a rise in the demand for safe drug handling due to increasing awareness around infection control.

    The Push to Turn System is noted for its intuitive design, simplifying the process for healthcare professionals in high-pressure environments. Color-to-color Alignment Systems enhance ease of use, promoting accuracy and minimizing human error during drug transfers.

    Meanwhile, Leur Lock Systems are vital for preventing leakage and ensuring a secure connection between devices, thereby increasing the safety of drug delivery. Lastly, Click Lock Systems are gaining traction due to their additional locking feature, which reassures users about the stability of connections.

    Overall, these systems contribute significantly to the GCC region's healthcare landscape by addressing the urgent need for risk mitigation in pharmaceutical care. With the ongoing improvements in medical technology and a regulatory push for safer drug-handling practices, this segment is anticipated to experience substantial growth in the coming years.

    Closed System Drug Transfer Device Market Technology Insights

    The Technology segment of the GCC Closed System Drug Transfer Device Market is characterized by a diverse range of devices designed to enhance safety during drug preparation and administration.

    This segment comprises several categories, including Compartmentalized Devices, Diaphragm-Based Devices, and Air Filtration Devices, each playing a crucial role in preventing contamination and exposure to hazardous substances. Compartmentalized Devices are vital as they help to maintain separate environments for different substances, thereby minimizing cross-contamination risks.

    Diaphragm-based devices are significant due to their ability to provide robust sealing mechanisms, which reduce the chances of leakage and enhance user safety. Meanwhile, Air Filtration Devices dominate the market as they ensure that any airborne contaminants are effectively filtered out during drug transfer processes.

    The ongoing emphasis on safety regulations in the GCC region further supports the need for advanced closed-system drug transfer technologies, ultimately driving growth and innovation in these device categories. With various applications in healthcare settings, these technologies represent key components in the evolution of drug safety protocols within the GCC healthcare industry.

    Closed System Drug Transfer Device Market

    The End-users segment of the GCC Closed System Drug Transfer Device Market plays a pivotal role in shaping the market dynamics within this region. Hospitals and Clinics represent a substantial portion of the user base, driven by an increasing demand for safety and efficacy in drug handling, reflecting the ongoing focus on patient safety protocols.

    Specialty Centers further enhance the market landscape, as they provide targeted treatments that often require sophisticated drug delivery systems. This trend is reinforced by the growing prevalence of chronic diseases in the GCC region, necessitating advanced drug transfer solutions.

    Other segments also contribute to the market, although to a lesser extent, by catering to specific applications that benefit from closed-system technology. The regulatory environment in the GCC encourages the adoption of innovative medical devices, ensuring that healthcare facilities stay compliant with safety standards.

    Overall, the End-users segment is marked by a steady emphasis on enhancing the quality of care through the integration of advanced drug transfer technologies, laying a foundation for sustained market growth in the coming years.

    Get more detailed insights about GCC Closed System Drug Transfer Device Market Research Report - Forecast to 2035

    Request Free Sample

    Regional Insights

    Key Players and Competitive Insights

    The GCC Closed System Drug Transfer Device Market has witnessed a robust evolution driven by the increasing awareness of safety protocols and stringent regulations surrounding handling hazardous drugs in healthcare settings.

    As a region that emphasizes advanced healthcare practices, the GCC has experienced a rise in demand for closed-system drug transfer devices to minimize the risk of exposure for healthcare workers and patients.

    Competitive insights into this market reveal that various players are strategically positioning themselves by offering innovative solutions that align with safety standards and enhance the drug delivery process. The emphasis on quality, efficiency, and regulatory compliance is critical in shaping the competitive landscape of the GCC closed system drug transfer device market.

    Companies are leveraging technological advancements to differentiate their products, enhance functionality, and expand their market presence.

    Becton Dickinson has established a substantial footprint in the GCC Closed System Drug Transfer Device Market by focusing on product innovation and adherence to safety standards. The company benefits from strong brand recognition and a reputation for reliability in providing medical devices that meet stringent regulatory compliance.

    Its extensive portfolio of closed system drug transfer devices, engineered for safety and efficiency, has gained traction among healthcare providers in the region. The strength of Becton Dickinson lies in its commitment to enhancing patient and healthcare worker safety, which is increasingly critical in today's healthcare environment.

    The company's active engagement in training and support services further reinforces its position, enabling healthcare professionals to effectively implement and utilize its products, thus solidifying Becton Dickinson's competitive advantage in the GCC market.

    BD Medical, a division of Becton Dickinson, plays a pivotal role in the GCC Closed System Drug Transfer Device Market, offering a range of key products tailored for safe medication handling. BD Medical's portfolio includes advanced closed system drug transfer devices designed to protect healthcare professionals from hazardous drug exposure while ensuring safe drug administration.

    The company boasts a strong market presence in the GCC, driven by its strategic investments in local partnerships and collaborations, which bolster its distribution channels and service capabilities. BD Medical's strengths lie in its focus on research and development, continually innovating to address the unique needs of the healthcare sector in the region.

    The company has engaged in mergers and acquisitions to enhance its capabilities and expand its product offerings, demonstrating a commitment to maintaining a competitive edge in the dynamic GCC market for closed-system drug transfer devices.

    Key Companies in the GCC Closed System Drug Transfer Device Market market include

    Industry Developments

    Recent developments in the GCC Closed System Drug Transfer Device Market are marked by an increasing focus on safety and efficiency in drug handling due to the rising awareness of occupational exposure risks among healthcare professionals.

    Notably, major players like Becton Dickinson and BD Medical are expanding their product lines to include more advanced solutions that comply with newly established regulatory guidelines aimed at enhancing safety standards in administering hazardous drugs.

    In terms of market dynamics, an uptick in hospital acquisitions and consolidation within the healthcare sector across the GCC has led to greater demand for high-quality Closed System Drug Transfer Devices by providers seeking to improve patient care and operational efficiencies.

    Additionally, in June 2022, C.R. Bard acquired a local firm in the GCC region, bolstering its market presence and enhancing its capabilities in drug delivery technology.

    The overall market valuation is anticipated to grow significantly as investments in healthcare infrastructure increase across GCC nations, such as Saudi Arabia and the UAE, as part of their national Vision 2030 initiatives. These developments reflect a strategic shift towards improving healthcare outcomes and safety protocols within the region.

    Market Segmentation

    Outlook

    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Closed System Drug Transfer Device Market Type Outlook

    • Membrane-to-membrane
    • Needleless System

    Closed System Drug Transfer Device Market Component Outlook

    • Vial Access Devices
    • Syringe Safety Devices
    • Accessories
    • Bag/Line Access Devices

    Closed System Drug Transfer Device Market End-users Outlook

    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Closed System Drug Transfer Device Market Technology Outlook

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices

    Closed System Drug Transfer Device Market Closing Mechanism Outlook

    • Push to Turn System
    • Color-to-color Alignment System
    • Leur Lock Systems
    • Click on Lock Systems

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 53.5(USD Million)
    MARKET SIZE 2024 90.0(USD Million)
    MARKET SIZE 2035 600.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 18.823% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Becton Dickinson, BD Medical, C.R. Bard, Medline Industries, Vygon, B. Braun, Terumo Corporation, Smiths Medical, COVESY, Aesculap, West Pharmaceutical Services, Fresenius Kabi, Sartorius, Corvida Medical, Innocore Medical
    SEGMENTS COVERED Type, Component, Closing Mechanism, Technology, End-Users
    KEY MARKET OPPORTUNITIES Growing oncology drug demand, Increased hospital investments, Regulatory compliance drive, Rising focus on safety standards, Expansion of healthcare infrastructure
    KEY MARKET DYNAMICS regulatory compliance requirements, increasing oncology drug demand, healthcare infrastructure development, rising awareness of safety, growing adoption of automation
    COUNTRIES COVERED GCC

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    What is the expected market size of the GCC Closed System Drug Transfer Device Market in 2024?

    The market is expected to be valued at 90.0 USD Million in 2024.

    What will be the projected market value of the GCC Closed System Drug Transfer Device Market by 2035?

    By 2035, the market is anticipated to reach a value of 600.0 USD Million.

    What is the expected compound annual growth rate (CAGR) for the GCC Closed System Drug Transfer Device Market from 2025 to 2035?

    The expected CAGR for the market is 18.823% during the period from 2025 to 2035.

    Which type will dominate the GCC Closed System Drug Transfer Device Market by 2035?

    The Needleless System is projected to dominate the market, reaching a value of 360.0 USD Million by 2035.

    What is the market value for the Membrane to Membrane segment in 2024?

    The Membrane to Membrane segment is valued at 42.0 USD Million in 2024.

    Who are the key players in the GCC Closed System Drug Transfer Device Market?

    Major players include Becton Dickinson, C.R. Bard, Medline Industries, and West Pharmaceutical Services, among others.

    What challenges may affect the growth of the GCC Closed System Drug Transfer Device Market?

    Challenges may include regulatory hurdles and concerns regarding product efficacy and safety.

    What opportunities exist within the GCC Closed System Drug Transfer Device Market?

    Opportunities include innovations in drug delivery systems and expansion into emerging markets.

    What is the anticipated impact of emerging trends on the GCC Closed System Drug Transfer Device Market?

    Emerging trends towards safety and efficiency in drug transfer are expected to drive market growth significantly.

    How does regionality affect the GCC Closed System Drug Transfer Device Market growth?

    Regionality influences the market based on varying healthcare infrastructure and regulatory policies across GCC countries.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. GCC Closed System Drug Transfer Device Market, BY Type (USD Million)
    45. Membrane to Membrane
    46. Needleless System
    47. GCC Closed System Drug Transfer Device Market, BY Component (USD Million)
    48. Vial Access Devices
    49. Syringe Safety Devices
    50. Accessories
    51. Bag/Line Access Devices
    52. GCC Closed System Drug Transfer Device Market, BY Closing Mechanism (USD Million)
    53. Push to Turn System
    54. Color-to-color Alignment System
    55. Leur Lock Systems
    56. Click to Lock Systems
    57. GCC Closed System Drug Transfer Device Market, BY Technology (USD Million)
    58. Compartmentalize Devices
    59. Diaphragm-Based Devices
    60. Air Filtration Devices
    61. GCC Closed System Drug Transfer Device Market, BY End-Users (USD Million)
    62. Hospitals & Clinics
    63. Specialty Centers
    64. Others
    65. Competitive Landscape
    66. Overview
    67. Competitive Analysis
    68. Market share Analysis
    69. Major Growth Strategy in the Closed System Drug Transfer Device Market
    70. Competitive Benchmarking
    71. Leading Players in Terms of Number of Developments in the Closed System Drug Transfer Device Market
    72. Key developments and growth strategies
    73. New Product Launch/Service Deployment
    74. Merger & Acquisitions
    75. Joint Ventures
    76. Major Players Financial Matrix
    77. Sales and Operating Income
    78. Major Players R&D Expenditure. 2023
    79. Company Profiles
    80. Becton Dickinson
    81. Financial Overview
    82. Products Offered
    83. Key Developments
    84. SWOT Analysis
    85. Key Strategies
    86. BD Medical
    87. Financial Overview
    88. Products Offered
    89. Key Developments
    90. SWOT Analysis
    91. Key Strategies
    92. C.R. Bard
    93. Financial Overview
    94. Products Offered
    95. Key Developments
    96. SWOT Analysis
    97. Key Strategies
    98. Medline Industries
    99. Financial Overview
    100. Products Offered
    101. Key Developments
    102. SWOT Analysis
    103. Key Strategies
    104. Vygon
    105. Financial Overview
    106. Products Offered
    107. Key Developments
    108. SWOT Analysis
    109. Key Strategies
    110. B. Braun
    111. Financial Overview
    112. Products Offered
    113. Key Developments
    114. SWOT Analysis
    115. Key Strategies
    116. Terumo Corporation
    117. Financial Overview
    118. Products Offered
    119. Key Developments
    120. SWOT Analysis
    121. Key Strategies
    122. Smiths Medical
    123. Financial Overview
    124. Products Offered
    125. Key Developments
    126. SWOT Analysis
    127. Key Strategies
    128. COVESY
    129. Financial Overview
    130. Products Offered
    131. Key Developments
    132. SWOT Analysis
    133. Key Strategies
    134. Aesculap
    135. Financial Overview
    136. Products Offered
    137. Key Developments
    138. SWOT Analysis
    139. Key Strategies
    140. West Pharmaceutical Services
    141. Financial Overview
    142. Products Offered
    143. Key Developments
    144. SWOT Analysis
    145. Key Strategies
    146. Fresenius Kabi
    147. Financial Overview
    148. Products Offered
    149. Key Developments
    150. SWOT Analysis
    151. Key Strategies
    152. Sartorius
    153. Financial Overview
    154. Products Offered
    155. Key Developments
    156. SWOT Analysis
    157. Key Strategies
    158. Corvida Medical
    159. Financial Overview
    160. Products Offered
    161. Key Developments
    162. SWOT Analysis
    163. Key Strategies
    164. Innocore Medical
    165. Financial Overview
    166. Products Offered
    167. Key Developments
    168. SWOT Analysis
    169. Key Strategies
    170. References
    171. Related Reports
    172. GCC Closed System Drug Transfer Device Market SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD Billions)
    173. GCC Closed System Drug Transfer Device Market SIZE ESTIMATES & FORECAST, BY COMPONENT, 2019-2035 (USD Billions)
    174. GCC Closed System Drug Transfer Device Market SIZE ESTIMATES & FORECAST, BY CLOSING MECHANISM, 2019-2035 (USD Billions)
    175. GCC Closed System Drug Transfer Device Market SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD Billions)
    176. GCC Closed System Drug Transfer Device Market SIZE ESTIMATES & FORECAST, BY END-USERS, 2019-2035 (USD Billions)
    177. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    178. ACQUISITION/PARTNERSHIP
    179. MARKET SYNOPSIS
    180. GCC CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET ANALYSIS BY TYPE
    181. GCC CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET ANALYSIS BY COMPONENT
    182. GCC CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET ANALYSIS BY CLOSING MECHANISM
    183. GCC CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET ANALYSIS BY TECHNOLOGY
    184. GCC CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET ANALYSIS BY END-USERS
    185. KEY BUYING CRITERIA OF CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET
    186. RESEARCH PROCESS OF MRFR
    187. DRO ANALYSIS OF CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET
    188. DRIVERS IMPACT ANALYSIS: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET
    189. RESTRAINTS IMPACT ANALYSIS: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET
    190. SUPPLY / VALUE CHAIN: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET
    191. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE, 2025 (% SHARE)
    192. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE, 2019 TO 2035 (USD Billions)
    193. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT, 2025 (% SHARE)
    194. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT, 2019 TO 2035 (USD Billions)
    195. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM, 2025 (% SHARE)
    196. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM, 2019 TO 2035 (USD Billions)
    197. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TECHNOLOGY, 2025 (% SHARE)
    198. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TECHNOLOGY, 2019 TO 2035 (USD Billions)
    199. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY END-USERS, 2025 (% SHARE)
    200. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY END-USERS, 2019 TO 2035 (USD Billions)
    201. BENCHMARKING OF MAJOR COMPETITORS

    GCC Closed System Drug Transfer Device Market Segmentation

    • Closed System Drug Transfer Device Market By Type (USD Million, 2019-2035)

      • Membrane to Membrane
      • Needleless System

    • Closed System Drug Transfer Device Market By Component (USD Million, 2019-2035)

      • Vial Access Devices
      • Syringe Safety Devices
      • Accessories
      • Bag/Line Access Devices

    • Closed System Drug Transfer Device Market By Closing Mechanism (USD Million, 2019-2035)

      • Push to Turn System
      • Color-to-color Alignment System
      • Leur Lock Systems
      • Click to Lock Systems

    • Closed System Drug Transfer Device Market By Technology (USD Million, 2019-2035)

      • Compartmentalize Devices
      • Diaphragm-Based Devices
      • Air Filtration Devices

    • Closed System Drug Transfer Device Market By End-Users (USD Million, 2019-2035)

      • Hospitals & Clinics
      • Specialty Centers
      • Others
    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027